BlockBeats News, September 11, MEI Pharma, a U.S.-listed company, announced that it has changed its name to Litecoin Strategy (Nasdaq: LITS).
During intraday trading, the company's stock price is currently up by 10.61%, with a market capitalization of $101 million.